From £7.99 per month
ShareProphets
The one stop source for breaking news, expert analysis, and podcasts on fast-moving AIM and LSE listed shares

MINDING THE LSE’S BUSINESS

Join for as low as £7.99 per month

With ShareProphets’ membership, you receive:

• All premium articles

• Tom Winnifrith’s Bearcast

• Access to all the entire nearly 10 year archive

• ShareProphets Daily Newsletter

PZ Cussons is still a bad day buy

By Chris Bailey of Financial Orbit | Sunday 13 February 2022


Disclosure: I own shares in one or more of the stocks mentioned. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from ShareProphets). I have no business relationship with any company whose stock is mentioned in this article.


It has been another busy week and – despite the fact it is half term holiday time for some – it will be another  hectic seven days for a bunch of corporate news, macroeconomic matters and geopolitical discussions.  If you want a quiet life in the investment world then wait for Christmas.  One stock that reported over the last week but which I have not had an opportunity yet to comment on is PZ Cusson (PZC) which ‘builds brands to serve consumers better with Hygiene, Baby and Beauty at our core’ in brands such as Carex, St. Tropez, Cussons Baby, Sanctuary Spa, Morning Fresh (depending on which part of the world you live in). 

Premium content is for paid subscribers only
ShareProphets is reader-supported journalism

Become a member starting at £6.99 per month for all articles, the Bearcast, and our seven year archive.


Filed under:



Subscribe to our newsletter

Daily digest of our latest stories.



Search ShareProphets

Market News

Complete Coverage

Recent Comments

That Was the Week that Was

 

AAU

Gold up Ariana down

Saturday »

AVCT

Cassava, A warning to Avacta Sharehoders 

Friday »

ALU

Alumasc Group – a growth Buy

 

VCP

Victoria - The roll up unravels

 

HEMO

Hemogenyx is a short – target 0p

 

ECR

ECR, the timing is unfortunate

 

APH

Alliance Pharma – a recovery Buy?

Time left: 17:54:29